Reclast (zoledronic acid or zoledronate) is approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in males, females after menopause, and people taking glucocorticoids.

Infusions might be recommended when oral medications aren’t suitable, potentially improving treatment adherence and reducing gastrointestinal side effects. Zoledronic acid and ibandronate are ...

Medicare covers the injectable drug, Reclast, when a doctor deems it medically necessary for the treatment and prevention of osteoporosis. There are specific eligibility criteria, including having ...